{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003881","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.112043+00:00","generated_at":"2026-05-19T08:27:53.668943+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Corvus Pharmaceuticals 2025 Annual Meeting results: all proposals approved","bullets":["Elected Class III directors Ian T. Clark (28.9M for, 10.4M withheld) and Peter A. Thompson (38.8M for, 0.4M withheld).","Ratified PricewaterhouseCoopers as independent auditor for FY2025: 53.1M for, 0.1M against, 0.1M abstain.","Non-binding advisory vote on named executive officer compensation passed: 37.1M for, 2.1M against, 63.8k abstain.","53.4M shares voted of 68.2M outstanding; broker non-votes of 14.1M on director and compensation proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003881","json":"https://secwatch.observer/filing/0001171843-25-003881.json","markdown":"https://secwatch.observer/filing/0001171843-25-003881.md","text":"https://secwatch.observer/filing/0001171843-25-003881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184325003881/0001171843-25-003881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184325003881/f8k_061325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:27:53.668943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}